|
| |
transkaryotic therapies Pages on BioPortfolio:
Biotechnology News Transkaryotic Therapies Search
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...
|
BioPortfolio - Transkaryotic Therapies Incorporated RKT
Transkaryotic Therapies Incorporated RKT - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/10324-Transkaryotic...
|
Biotechnology News Shire Search
Former shareholders of Cambridge, MA-based Transkaryotic. .... litigation in connection with former dissenting shareholders of Transkaryotic Therapies, Inc.
...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...
|
BioPortfolio - Biocorporate Search
Founded in 1988, Transkaryotic Therapies, Inc. (TKT) is a leading biopharmaceutical company in the production and delivery of protein therapies.
...
http://www.bioportfolio.com/biocorporate/search.php?allticke...
|
Biotechnology News lawsuit legal tkt. shire. 1256. adhd. 9715 ...
Irish drug maker Shire (LSE:SHP) has settled claims from investors of former Cambridge, MA-based Transkaryotic Therapies (TKT) for $37 per share, ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
Erythropoietin State of the Science and Strategic Opportunities
... process of launching Dynepo, a gene-activated-erythropoietin from Transkaryotic therapies. Generics have already entered the markets of South East
Asia. ...
http://www.bioportfolio.com/reports/Erythropoietin%20State%2...
|
BioPortfolio.com - BioWeb Fabry Disease Search
Transkaryotic Therapies Complete a new search Drug Name (Proprietary name/ Generic name) Indications Addressed Click on indication to see all drugs for
that ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...
|
The Board of International Biotechnology Trust Plc (“IBT”) today ...
27 Sep 2005 ... Pfizer announced the acquisition of Vicuron, which still has to complete, and Shire has acquired Transkaryotic Therapies, Inc.. ...
http://www.bioportfolio.com/news/International_Biotechnology...
|
BioPortfolio.com - BioWeb ACUTECT TECHNETIUM TC 99M APCITIDE Search
San Francisco, CA DNase recombinant Replagal Transkaryotic Therapies enzyme Fabry's disease Phase II x- galactosidase A Cambridge, MA replacement therapy
...
http://www.bioportfolio.co.uk/ACUTECT+TECHNETIUM+TC+99M+APCI...
|
NASDAQ Biotechnology Companies - sangamo - zymogenetics
TTP · TITAN PHARMACEUTICALS INC, AMEX, Biotech. TBIO · TRANSGENOMICS INC, Nasdaq , Biotech. TKTX · TRANSKARYOTIC THERAPIES INC, Nasdaq, Biotech ...
http://www.bioportfolio.com/nasdaq/nasdaq_sangamo_zymogeneti...
|
Results from other life science and pharmaceutical sites:
Shire
Shire focuses its business on attention deficit and hyperactivity disorder, human genetic therapies and gastrointestinal diseases. ...
http://www.shire.com/...
|
BioSpace - Transkaryotic Therapies, Inc. News, Search Jobs, Events
19 Oct 2005 ... Transkaryotic Therapies, Inc. 700 Main Street Cambridge Massachusetts 02139 U.S.A. Phone: 617-349-0200 Fax: 617-613-4004 ...
http://www.biospace.com/company_profile.aspx?CompanyID=1548...
|
Shire
On July 28, 2005 Shire acquired Transkaryotic Therapies, Inc. ... TKT’s enabling gene therapy technology, known as Transkaryotic Therapy, is a non-viral ex ...
http://www.shire.com/shire/Pipeline/technology/genetherapy.j...
|
BioPortfolio - Transkaryotic Therapies Incorporated RKT
Transkaryotic Therapies Incorporated RKT - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/10324-Transkaryotic...
|
Transkaryotic Therapies, Inc. Company Profile - Yahoo! Finance
Capsule info for Transkaryotic Therapies, Inc. ... Transkaryotic Therapies (TKT) has found its niche in niche drugs. Targeting rare diseases, it develops ...
http://biz.yahoo.com/ic/52/52232.html...
|
Biotech, Clinical Research, Pharmaceutical News & Jobs
New Therapy Could Transform Arthritis Treatment, Medical Research Council Study More... 'Invisible' Transplant Organs Now In Sight, Hammersmith Hospital And ...
http://www.biospace.com/Default.aspx...
|
TKTX: Profile for - Yahoo! Finance
See the company profile for (TKTX) including business summary, industry/sector information, number of employees, business summary, corporate governance, ...
http://biz.yahoo.com/p/T/TKTX.html...
|
Corporate and Chancery
Transkaryotic Therapies, Inc. (“tkt”) with and into ... In re Appraisal of Transkaryotic Therapies, Inc.: Delaware Court of ...
http://www.fr.com/news/DCCsummary_FINAL.pdf...
|
Shire: Events Calendar
Shire to acquire Transkaryotic Therapies Inc. (TKT) for $1.6 Billion. Matthew Emmens, Chief Executive Officer Matthew Emmens, Chief Executive Officer ...
http://www.shire.com/shire/InvestorRelations/showevent.jsp?t...
|
TKT and Aventis Pharma Provide Update on GA-EPO Patent Litigation
Transkaryotic Therapies, Inc. (TKT) is a biopharmaceutical company dedicated to the development and commercialization of products based on its three ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
|
